3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
10
Transitional Cell Carcinoma of the Bladder
1
Muscle Invasive Bladder Cancer
1
Cone Dystrophy 3
1
Bladder Adenocarcinoma
1
Interventions
Gemcitabine
5
Cisplatin
4
enfortumab vedotin
2
Ramucirumab
2
Platinum
2
Docetaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
vinflunine
1
rucaparib
1
pembrolizumab
1
eribulin
1
enzalutamide
1
dehydroftorafur
1
carotuximab
1
avelumab
1
atezolizumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Interleukin-7
1
Immunoglobulin G
1
Icrucumab
1
IMC-18F1
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ureteral Neoplasms
×
Cystectomy
×
Clear all
No trials found.